EXOZYMES INC (EXOZ) Stock News

USA - Nasdaq - NASDAQ:EXOZ - US4618741098 - Common Stock

14.01 USD

-0.11 (-0.78%)

Last: 12/9/2025, 8:00:02 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

EXOZ Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: ACCESS Newswire

eXoZymes Provides Third Quarter 2025 Update at 5PM EST Today

a month ago - By: ACCESS Newswire

eXoZymes Announces Cell-Free Biomanufacturing Pioneer, Tyler Korman, As CSO & Amy Lunzer as Chief of Staff

a month ago - By: ACCESS Newswire

eXoZymes to Host Third Quarter 2025 Update on Thursday November 13, 2025, at 5PM EST

a month ago - By: Benzinga - Mentions: MNOV INTS KALA EDSA ...

12 Health Care Stocks Moving In Friday's After-Market Session

a month ago - By: ACCESS Newswire

CEO of eXoZymes on 'AI in Life Sciences' panel at the Beryl Elites' Investment Conference

a month ago - By: ACCESS Newswire

CEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor Conference

4 months ago - By: ACCESS Newswire

eXoZymes Provides Second Quarter 2025 Update at 5PM EST Today

4 months ago - By: ACCESS Newswire

eXoZymes Details Biomanufacturing Breakthrough: 4 Grams of NCT with Over 99% Purity

a month ago - By: Benzinga - Mentions: ECC VINP INV VTGN ...

Earnings Scheduled For November 13, 2025

7 months ago - By: ACCESS Newswire

eXoZymes Provides First Quarter 2025 and NCTx Subsidiary Update at 5PM EST Today

2 months ago - By: ACCESS Newswire

CEO of eXoZymes to Present at ThinkEquity's Annual Investor Conference

2 months ago - By: ACCESS Newswire

Driving the Cell-Free Revolution: eXoZymes Leaders Join BioMADE Leadership & Technical Committees

4 months ago - By: ACCESS Newswire

eXoZymes to Host Second Quarter 2025 Update on Tuesday August 12, 2025, at 5PM EST

5 months ago - By: ACCESS Newswire

eXoZymes Biomanufacturing Breakthrough: From Concept to Gram-Scale NCT in Only 5 Months

6 months ago - By: ACCESS Newswire

eXoZymes Selected as Core Industry Partner in $9M NSF-Funded Initiative to Advance Modular Cell-Free Biomanufacturing

7 months ago - By: ACCESS Newswire

eXoZymes Highlights Scalable Biomanufacturing Platform and First Spinout, NCTx, on Grow Everything Podcast

7 months ago - By: ACCESS Newswire

eXoZymes to Host First Quarter 2025 and Subsidiary NCTx Update on Monday May 12, 2025, at 5PM EST

7 months ago - By: ACCESS Newswire

eXoZymes Launches Subsidiary, NCTx, to Unlock a Promising Compound for Gut and Liver Health

8 months ago - By: eXoZymes Inc.

Bringing clarity and precision to the cell-free space by introducing exozymes

8 months ago - By: eXoZymes Inc.

Bringing clarity and precision to the cell-free space by introducing exozymes

8 months ago - By: ACCESS Newswire - Mentions: HIT BIVI SGTM

New to The Street's FOX Business "Late Night T.V." Special Airs Tonight – Show #650 – Featuring Health In Tech CEO Julia Qian (NASDAQ:HIT), BioVie's Dr. Joseph Palumbo (NASDAQ:BIVI), eXoZymes Co-Founder & VP of Research Tyler Korman (EXOZ), and ARRIVE AI

8 months ago - By: eXoZymes Inc.

BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant

8 months ago - By: eXoZymes Inc.

BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant

8 months ago - By: eXoZymes Inc.

eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO

8 months ago - By: eXoZymes Inc.

eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO

8 months ago - By: eXoZymes Inc.

eXoZymes Provides Fourth Quarter and Full Year 2024 Update

8 months ago - By: eXoZymes Inc.

eXoZymes Provides Fourth Quarter and Full Year 2024 Update

9 months ago - By: eXoZymes Inc.

eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025

9 months ago - By: eXoZymes Inc.

eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025

9 months ago - By: ACCESS Newswire - Mentions: RDZN ATCH BIVI

New to the Street Airs Show #630 on Fox Business Network Tonight at 10:30 PM PST Featuring Roadzen ($RDZN), BioVie ($BIVI), AtlasClear (ATCH), eXoZymes ($EXOZ), and EvolveHealthandLifestyle.com With Craig Bruce

10 months ago - By: eXoZymes Inc.

eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.

10 months ago - By: eXoZymes Inc.

eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.